Financial Year |
March 31 2023 |
Monetary Funds |
2,867,531,644.74 |
Held-for-trading Financial Assets |
393,755,108.65 |
Notes Receivable |
102,317,926.73 |
Accounts Receivable |
1,091,854,732.16 |
Advances to Suppliers |
793,416,702.03 |
Other Receivables |
287,510,282.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
5,462,544,089.40 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,540,187.78 |
Other Current Assets |
139,987,580.16 |
Total Current Assets |
11,140,458,253.94 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
2,889,571.11 |
Long-term Equity Investment |
322,368,836.59 |
Investment Properties |
64,820,201.89 |
Fixed Assetes |
4,851,825,784.68 |
Under-construction Projects |
415,360,431.70 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
939,709,957.85 |
R&D expenses |
-- |
Goodwill |
157,486,295.49 |
Long-Term Deferred and Prepaid Expenses |
28,201,701.67 |
Deferred Income Tax Assets |
181,107,541.89 |
Other Non-Current Assets |
59,879,848.17 |
Sub-Total of Non-Current Assets |
7,123,442,075.26 |
Total Assets |
18,263,900,329.20 |
Short-Term Loans |
6,760,560,912.34 |
Trading Financial liabilities |
1,902,600.00 |
Notes Payable |
62,199,979.26 |
Accounts Payable |
1,143,501,523.13 |
Accounts Received In Advance |
10,439,802.87 |
Employee Compensation Payable |
78,681,063.33 |
Taxes Payable |
75,227,367.91 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
248,116,119.89 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
190,277,750.21 |
Other Current Liabilities |
145,667,058.56 |
Sub-Total of Current Liabilities |
9,974,087,849.97 |
Long-term Loans |
1,213,398,640.29 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
224,367,138.45 |
Special Payable |
-- |
Estimatied Liabilities |
218,082.48 |
Deferred Income Tax Liabilities |
21,141,748.87 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,571,437,879.12 |
Total Liabilities |
11,545,525,729.09 |
Paid-In Capital(Or Share Stock) |
1,700,681,355.00 |
Capital Surplus |
2,740,826,583.55 |
Surplus Reserve |
302,737,887.79 |
LESS:Treasury Stock |
100,048,630.86 |
Undistributed Profits |
1,695,558,913.23 |
Minority Stockholder's Interest |
482,901,986.83 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,235,472,613.28 |
Owner's Equity(Stockholder's Equity) |
6,718,374,600.11 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
18,263,900,329.20 |